Lanzhou Foci Pharmaceutical Co Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lanzhou Foci Pharmaceutical Co Limited with three other
companies in this sector in China:
Beijing Beilu Pharmaceutical Company Limited
sales of 522.54 million Chinese Renmimbi [US$75.17 million]
of which 99%
was Pharmaceutical Sales),
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
(497.69 million Chinese Renmimbi [US$71.60 million]
Honz Pharmaceutical Co Ltd
(480.81 million Chinese Renmimbi [US$69.17 million]
of which 100%
was Medical Industry).
During the year ended December of 2017, sales at
Lanzhou Foci Pharmaceutical Co Limited were 501.14 million Chinese Renmimbi (US$72.09 million).
increase of 38.0%
versus 2016, when the company's sales were 363.22 million Chinese Renmimbi.
Sales of Pharmacies saw an increase
38.5% in 2017, from
360.30 million Chinese Renmimbi to 498.88 million Chinese Renmimbi.
Not all segments of Lanzhou Foci Pharmaceutical Co Limited experienced an increase in sales in 2017:
sales of Food fell 23.7% to 2.26 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).